NCT00998036
- Conditions
- Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
- Locations
-
- Columbia University Medical Center New York, United States
Clinical trial condition
Triple Negative Breast Cancer
Explore clinical trials studying Triple Negative Breast Cancer. Study availability and eligibility vary by location and protocol.
294 public trials
113 recruiting studies
Triple Negative Breast Cancer trial results
Completed
Abraxane With or Without Tigatuzumab in Patients With Metastatic, Triple Negative Breast Cancer
NCT01307891
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +8 more
- Locations
-
- University of Alabama at Birmingham (UAB) Birmingham, Alabama, United States
- Georgetown University Medical Center Washington D.C., District of Columbia, United States
- University of Chicago Chicago, Illinois, United States
- Indiana University Melvin and Bren Simon Cancer Center Indianapolis, Indiana, United States
NCT01639248
- Conditions
- Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
- Locations
-
- University of Colorado Cancer Center Aurora, Colorado, United States
- Inidiana University Melvin and Bren Simon Cancer Center Indianapolis, Indiana, United States
- Cancer Hospital of Chinese Academy of Medical Science Beijing, China
NCT01451632
- Conditions
- Breast Diseases, Breast Neoplasms, Bronchial Neoplasms, +27 more
- Locations
-
- San Francisco, California, United States
- Boston, Massachusetts, United States
- Chapel Hill, North Carolina, United States
- Salt Lake City, Utah, United States
NCT00813956
- Conditions
- Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
- Locations
-
- Stanford Comprehensive Cancer Center Stanford, California, United States
- PrECOG Philadelphia, Pennsylvania, United States
NCT01677455
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +8 more
- Locations
-
- Synta Pharmaceuticals Investigative Site Birmingham, Alabama, United States
- Synta Pharmaceuticals Investigative Site Altanta, Georgia, United States
- Synta Pharmaceuticals Investigative Site Boston, Massachusetts, United States
- Synta Pharmaceuticals Investigative Site New York, United States
NCT00951054
- Conditions
- Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
- Locations
-
- Sarah Cannon Research Institute Nashville, Tennessee, United States
Completed
Induction Preoperative Chemotherapy for Patients With Locally Advanced Triple Negative Breast Cancer
NCT01969032
- Conditions
- Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
- Locations
-
- Russian Cancer Research Center named after N.N.Blokhin RAMS Moscow, Russia
NCT01111175
- Conditions
- Breast Diseases, Breast Neoplasms, Metastatic Breast Cancer, +6 more
- Locations
-
- Rocky Mountain Cancer Centers Denver, Colorado, United States
- Virginia Oncology Assocites Elizabeth City, North Carolina, United States
- Northwest Cancer Specialists, P.C. Portland, Oregon, United States
- Northwest Cancer Specialists, P.C. Portland, Oregon, United States
Active, Not Recruiting
Atezolizumab Combined With BDB001 AnD Immunogenic Radiotherapy in Patients With Advanced Solid Tumors
NCT03915678
- Conditions
- Bladder Cancer, Breast Diseases, Breast Neoplasms, +45 more
- Locations
-
- Institut Bergonié Bordeaux, France
- Chu Brest Brest, France
- Centre François Baclesse Caen, France
- Centre Georges François Leclerc Dijon, France